SQZ Biotech
An industry veteran of large, mid-size, and small biopharma companies with 20+ years of experience in clinical development and operations for oncology, immuno-oncology, and cell therapy agents. Expertise in global clinical programs at Eli Lilly, Takeda, Epizyme, and, most recently, Trillium Therapeutics, which was acquired by Pfizer for its CD47 program.
This person is not in any offices
SQZ Biotech
1 followers
SQZ Biotech is a company founded out of the Massachusetts Institute of Technology (MIT). At SQZ they have developed a high-throughput platform - CellSqueeze - for simple and effective material delivery into cells.